Treatment of generalized morphea with oral 1.25-Dihydroxyvitamin D3

Advances in Experimental Medicine and Biology

Volumn 455, Issue , 1999, Pages 299-304

  Caca Biljanovska, N G ^a   Vlckova Laskoska, M T ^a   Dervendi, D V ^a   Pesic, N P ^a   Laskoski, D S ^a  

^a University in Skopje   (Macedonia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; CORTICOSTEROID; CREATININE; PENICILLIN G; PHOSPHATE;

ADULT; CASE REPORT; COLLAGEN SYNTHESIS; CONFERENCE PAPER; CONNECTIVE TISSUE DISEASE; FEMALE; HUMAN; IMMUNOPATHOLOGY; MORPHEA; PRIORITY JOURNAL; SCLERODERMA; SIDE EFFECT; TREATMENT OUTCOME;

HUMBERT; SCLERODERMA;

EID: 0033281959     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4857-7_44     Document Type: Conference Paper

References (10)

1. 3
2. 3: Evaluation of skin involvement using non-invasive techniques
3. 3
4. Oral calcitriol as a new therapeutic modality for generalized morphea
5. Effects of calcitriol on fibroblasts derived from skin of scleroderma patients
6. 3 analogues
7. 3
8. 3 in control of bone marrow colagen deposition?
9. Effect of a plateled release fraction on glycosaminoglycan synthesis by cultured dermal fibroblasts from patients with progressive systemic sclerosis
10. 3 (calcitriol)